Eslicarbazepine Acetate

Back to search

Molecule Structure

Scientific Name

Eslicarbazepine Acetate

Description of the Drug

Eslicarbazepine acetate is an anticonvulsant agent used as an adjunct to treat partial-onset seizures in patients with inadequate clinical response to conventional antiepileptic therapy.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB09119

Brand Name(s)

Aptiom, Erelib, Pazzul, Stedesa, Zebinix

Company Owner(s)

Sunovion Pharmaceuticals Inc, Dr Reddys Laboratories Ltd

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Sodium channel alpha subunit PROTEIN FAMILY BLOCKER CHEMBL2331043

Unichem Links

SureChEMBL SCHEMBL250594
DrugBank DB09119
PubChem: Thomson Pharma 14800284 14825046
PubChem 179344
Nikkaji J1.143.147J
BindingDB 50240669
EPA CompTox Dashboard DTXSID90178308
DrugCentral 4303
ChemicalBook CB5503197
rxnorm APTIOM ESLICARBAZEPINE ACETATE
PubChem: Drugs of the Future 85197631
ChEBI 87016
ZINC ZINC000000007295